These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Mesenchymal stromal cells from myelodysplastic and acute myeloid leukemia patients display in vitro reduced proliferative potential and similar capacity to support leukemia cell survival. Corradi G; Baldazzi C; Očadlíková D; Marconi G; Parisi S; Testoni N; Finelli C; Cavo M; Curti A; Ciciarello M Stem Cell Res Ther; 2018 Oct; 9(1):271. PubMed ID: 30359303 [TBL] [Abstract][Full Text] [Related]
6. The bone marrow stem stromal imbalance--a key feature of disease progression in case of myelodysplastic mouse model. Das M; Chatterjee S; Basak P; Das P; Pereira JA; Dutta RK; Chaklader M; Chaudhuri S; Law S J Stem Cells; 2010; 5(2):49-64. PubMed ID: 22049615 [TBL] [Abstract][Full Text] [Related]
7. Reserves, functional, immunoregulatory, and cytogenetic properties of bone marrow mesenchymal stem cells in patients with myelodysplastic syndromes. Klaus M; Stavroulaki E; Kastrinaki MC; Fragioudaki P; Giannikou K; Psyllaki M; Pontikoglou C; Tsoukatou D; Mamalaki C; Papadaki HA Stem Cells Dev; 2010 Jul; 19(7):1043-54. PubMed ID: 19788374 [TBL] [Abstract][Full Text] [Related]
8. Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality? Pleyer L; Valent P; Greil R Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27355944 [TBL] [Abstract][Full Text] [Related]
9. Common and different alterations of bone marrow mesenchymal stromal cells in myelodysplastic syndrome and multiple myeloma. Choi H; Kim Y; Kang D; Kwon A; Kim J; Min Kim J; Park SS; Kim YJ; Min CK; Kim M Cell Prolif; 2020 May; 53(5):e12819. PubMed ID: 32372504 [TBL] [Abstract][Full Text] [Related]
10. Biology of the bone marrow microenvironment and myelodysplastic syndromes. Rankin EB; Narla A; Park JK; Lin S; Sakamoto KM Mol Genet Metab; 2015; 116(1-2):24-8. PubMed ID: 26210353 [TBL] [Abstract][Full Text] [Related]
11. Inappropriate Notch activity and limited mesenchymal stem cell plasticity in the bone marrow of patients with myelodysplastic syndromes. Varga G; Kiss J; Várkonyi J; Vas V; Farkas P; Pálóczi K; Uher F Pathol Oncol Res; 2007; 13(4):311-9. PubMed ID: 18158566 [TBL] [Abstract][Full Text] [Related]
12. The immunological role of mesenchymal stromal cells in patients with myelodysplastic syndrome. Zheng L; Zhang L; Guo Y; Xu X; Liu Z; Yan Z; Fu R Front Immunol; 2022; 13():1078421. PubMed ID: 36569863 [TBL] [Abstract][Full Text] [Related]
14. [Senescent Mesenchymal Stem Cells Contribute to Progression of Myelodysplastic Syndromes-Review]. Pang YB; Li WW; Luo JM; Ji J; DU X Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Jun; 26(3):942-946. PubMed ID: 29950248 [TBL] [Abstract][Full Text] [Related]
15. Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes. Falconi G; Fabiani E; Fianchi L; Criscuolo M; Raffaelli CS; Bellesi S; Hohaus S; Voso MT; D'Alò F; Leone G Exp Hematol; 2016 Jan; 44(1):75-83.e1-4. PubMed ID: 26521017 [TBL] [Abstract][Full Text] [Related]
16. In vitro study of biological characteristics of mesenchymal stem cells in patients with low-risk myelodysplastic syndrome. Zhang YZ; Zhao DD; Han XP; Jin HJ; Da WM; Yu L Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):813-8. PubMed ID: 18718067 [TBL] [Abstract][Full Text] [Related]
17. Cytogenetic evaluation of mesenchymal stem/stromal cells from patients with myelodysplastic syndromes at different time-points during ex vivo expansion. Kouvidi E; Stratigi A; Batsali A; Mavroudi I; Mastrodemou S; Ximeri M; Papadaki HA; Pontikoglou CG Leuk Res; 2016 Apr; 43():24-32. PubMed ID: 26930455 [TBL] [Abstract][Full Text] [Related]
18. The mesenchymal compartment in myelodysplastic syndrome: Its role in the pathogenesis of the disorder and its therapeutic targeting. Pontikoglou CG; Matheakakis A; Papadaki HA Front Oncol; 2023; 13():1102495. PubMed ID: 36761941 [TBL] [Abstract][Full Text] [Related]
19. Coexistence of aberrant hematopoietic and stromal elements in myelodysplastic syndromes. Abbas S; Kini A; Srivastava VM; M MT; Nair SC; Abraham A; Mathews V; George B; Kumar S; Venkatraman A; Srivastava A Blood Cells Mol Dis; 2017 Jul; 66():37-46. PubMed ID: 28822917 [TBL] [Abstract][Full Text] [Related]
20. Differential expression of AURKA and AURKB genes in bone marrow stromal mesenchymal cells of myelodysplastic syndrome: correlation with G-banding analysis and FISH. Oliveira FM; Lucena-Araujo AR; Favarin Mdo C; Palma PV; Rego EM; Falcão RP; Covas DT; Fontes AM Exp Hematol; 2013 Feb; 41(2):198-208. PubMed ID: 23092930 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]